| |
|
|
|
Adial Pharmaceuticals Inc  
|
|
2.02 -0.14 (-0.06%) |
03-05 12:03 |
|
Open: |
2.13 |
Pre close: |
2.16 |
Target:
|
3.21 
|
|
High: |
2.18 |
Low: |
1.85 |
Resistance:
|
2.75
3.30
|
|
Volume: |
385,391 |
Market Cap: |
31M |
Support:
|
1.85
1.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.26
|
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
2.77 |
Signal(12,26,9): |
0.09 |
|
MA(100): |
2.09 |
Stochastic Oscillator |
%K(14,3):
|
3.97 |
|
MA(250): |
1.72  |
%D(3): |
7.80 |
|
Average Volume(K) |
3-Month: |
68777
|
52-Week |
High:
|
4.00 |
|
10-Days: |
101976 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
33.71 |
Change(%): |
40.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.823 |
Return on Equity (ttm) |
-119.9 |
Shares Out. (M) |
14.39 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-67.5 |
Shares Float (M) |
11.80 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.53 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.82 |
|
Forward EPS |
-0.870 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
370 |
|
Book Value (p.s.) |
0.500 |
EBITDA (p.s.) |
-0.664 |
P/E |
-2.27 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.73 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.77 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.26 |
P/CF |
-3.96 |
|
|
|
|
|
|
